• 1
    Levine AM,Seneviratne L,Espina BM, et al. Evolving characteristics of AIDS-related lymphoma. Blood 2000; 96: 40844090.
  • 2
    Cote TR,Biggar RJ,Rosenberg PS, et al. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 1997; 73: 645650.
  • 3
    Biggar RJ,Engels EA,Frisch M,Goedert JJ. Risk of T-cell lymphomas in persons with AIDS. J Acquir Immune Defic Syndr 2001; 26: 371376.
  • 4
    Chadburn A,Cesarman E,Jagirdar J, et al. CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus. Cancer 1993; 72: 30783090.
  • 5
    Gold JE,Ghali V,Gold S, et al. Angiocentric immunoproliferative lesion/T-cell non-Hodgkin's lymphoma and the acquired immune deficiency syndrome: A case report and review of the literature. Cancer 1990; 66: 24072413.
  • 6
    Gonzalez-Clemente JM,Ribera JM,Campo E, et al. Ki-1+ anaplastic large-cell lymphoma of T-cell origin in an HIV-infected patient. Aids 1991; 5: 751755.
  • 7
    Herndier BG,Shiramizu BT,Jewett NE, et al. Acquired immunodeficiency syndrome-associated T-cell lymphoma: Evidence for human immunodeficiency virus type 1-associated T-cell transformation. Blood 1992; 79: 17681774.
  • 8
    Kobayashi M,Yoshimoto S,Fujishita M, et al. HTLV-positive T-cell lymphoma/leukaemia in an AIDS patient. Lancet 1984; 1: 13611362.
  • 9
    Nasr SA,Brynes RK,Garrison CP,Chan WC. Peripheral T-cell lymphoma in a patient with acquired immune deficiency syndrome. Cancer 1988; 61: 947951.
  • 10
    Pantanowitz L,Castillo J,Freeman JK,Dezube BJ. Images in HIV/AIDS. Fatal HIV-associated anaplastic large-cell lymphoma. AIDS Read 2009; 19: 1921.
  • 11
    Proca DM,De Renne L,Marsh WLJr,Keyhani-Rofagha S. Anaplastic large cell lymphoma in a human immunodeficiency virus-positive patient with cytologic findings in bladder wash: A case report. Acta Cytol 2008; 52: 8386.
  • 12
    Shibata D,Brynes RK,Rabinowitz A, et al. Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1). Ann Intern Med 1989; 111: 871875.
  • 13
    Tisdale G,Mahadevan A,Matthews RH. T-cell lymphoma of the rectum in a patient with AIDS and hepatitis C: A case report and discussion. Oncologist 2005; 10: 292298.
  • 14
    Arzoo KK,Bu X,Espina BM, et al. T-cell lymphoma in HIV-infected patients. J Acquir Immune Defic Syndr 2004; 36: 10201027.
  • 15
    Brimo F,Michel RP,Khetani K,Auger M. Primary effusion lymphoma: A series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 2007; 111: 224233.
  • 16
    Collins JA,Hernandez AV,Hidalgo JA, et al. High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru. J Acquir Immune Defic Syndr 2005; 40: 558564.
  • 17
    Nava VE,Cohen P,Kalan M,Ozdemirli M. HIV-associated anaplastic large cell lymphoma: A report of three cases. Aids 2008; 22: 18921894.
  • 18
    Castillo J,Perez K,Milani C, et al. Peripheral T-cell lymphomas in HIV-infected individuals: A comprehensive review. J HIV Ther 2009; 14: 3440.
  • 19
    Swerdlow S,Campo E,Harris N, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.
  • 20
    A predictive model for aggressive non-Hodgkin's lymphoma. The international non-Hodgkin's lymphoma prognostic factors project. N Engl J Med 1993; 329: 987994.
  • 21
    Gallamini A,Stelitano C,Calvi R, et al. Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 24742479.
  • 22
    Kaplan EL,Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457481.
  • 23
    Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50: 163170.
  • 24
    Cox DR. Regression models and life-tables. J R Stat Soc 1982; 34: 187220.
  • 25
    Vose J,Armitage J,Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes. J Clin Oncol 2008; 26: 41244130.
  • 26
    Tanaka PY,Pracchia LF,Bellesso M, et al. A prognostic score for AIDS-related diffuse large B-cell lymphoma in Brazil. Ann Hematol 2009. Jun 4 [Epub ahead of print].
  • 27
    Castillo J,Pantanowitz L,Dezube BJ. HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases. Am J Hematol 2008; 83: 804809.
  • 28
    Levine AM. Acquired immunodeficiency syndrome-related lymphoma. Blood 1992; 80: 820.
  • 29
    Savage KJ,Harris NL,Vose JM, et al. ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: Report from the international peripheral t-cell lymphoma project. Blood 2008; 111: 54965504.
  • 30
    Perez K,Castillo J,Dezube BJ,Pantanowitz L. Human immunodeficiency virus-associated anaplastic large cell lymphoma. Leuk Lymph 2010; 51: 430438.
  • 31
    Aozasa K,Takakuwa T,Hongyo T,Yang WI. Nasal NK/T-cell lymphoma: Epidemiology and pathogenesis. Int J Hematol 2008; 87: 110117.
  • 32
    Dupuis J,Emile JF,Mounier N, et al. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study. Blood 2006; 108: 41634169.
  • 33
    Herling M,Rassidakis GZ,Jones D, et al. Absence of Epstein-Barr virus in anaplastic large cell lymphoma: A study of 64 cases classified according to World Health Organization criteria. Hum Pathol 2004; 35: 455459.
  • 34
    Diez-Martin JL,Balsalobre P,Re A, et al. Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood 2009; 113: 60116014.
  • 35
    Lim ST,Karim R,Tulpule A, et al. Prognostic factors in HIV-related diffuse large-cell lymphoma: Before versus after highly active antiretroviral therapy. J Clin Oncol 2005; 23: 84778482.
  • 36
    Simcock M,Blasko M,Karrer U, et al. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: Findings from the Swiss HIV Cohort Study. Antivir Ther 2007; 12: 931939.
  • 37
    Miralles P,Berenguer J,Ribera JM, et al. Prognosis of AIDS-related systemic non-Hodgkin lymphoma treated with chemotherapy and highly active antiretroviral therapy depends exclusively on tumor-related factors. J Acquir Immune Defic Syndr 2007; 44: 167173.
  • 38
    Mounier N,Spina M,Gabarre J, et al. AIDS-related non-Hodgkin lymphoma: Final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 2006; 107: 38323840.
  • 39
    Ribera JM,Navarro JT. Human immunodeficiency virus-related non-Hodgkin's lymphoma. Haematologica 2008; 93: 11291132.
  • 40
    Hoffmann C,Wolf E,Fatkenheuer G, et al. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma. Aids 2003; 17: 15211529.